| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On Friday, Cathie Wood-led Ark Invest made significant trades involving Teradyne Inc. (NASDAQ:TER), Meta Platforms Inc. (NASDAQ:META), Caris Life Sciences Inc. (NASDAQ:CAI) and Guardant Health Inc. (NASDAQ:GH).
The META Trade
Ark Invest sold 2,106 shares of Meta Platforms through its ARK Innovation ETF (BATS:ARKK).
The value of the Meta trade, calculated from the latest closing price, is around $1.48 million.
The TER Trade
Ark Invest purchased 39,792 shares of Teradyne through the ARKK fund. Teradyne is a leading supplier of automation equipment for test and industrial applications.
This move aligns with Wood’s recent emphasis on the disruptive impact of artificial intelligence on the job market, as highlighted in a recent video shared by Ark Invest.
The value of the Teradyne trade, calculated from the latest closing price, is around $3.74 million.
The CAI Trade
Ark Invest bought 13,036 shares of Caris Life Sciences through ARK Genomic Revolution ETF (BATS:ARKG).
The value of the Caris Life Sciences trade, calculated from the latest closing price, is around $393K.
The GH Trade
Ark Invest sold 3,013 shares of Guardant Health through ARKG.
The value of the Guardant Health trade, calculated from the latest closing price, is around $140K.
Read Next:
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: ChrisStock82 / Shutterstock.com
